Journal: Oncogene
Article Title: FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations
doi: 10.1038/s41388-023-02800-9
Figure Lengend Snippet: A Schematic diagram representing erythroid differentiation with the specific phenotypic markers used. B Representative profiles of cells incubated with antibodies against Ter119 and CD71 and analysed by flow cytometry. C Histograms represent the mean % of each population for mice analysed (from 4 to 8 mice) according to Ter119 and CD71 markers and basophilic, polychromatic and acidophilic cells relative to 100% of bone marrow or spleen cells as described in A and B. Statistical analysis was carried out using the Mann‒Whitney test. Three types of comparisons were performed: FA −/− to TgSpi1FA −/− ; FA +/+ to TgSpi1FA +/+ and TgSpi1FA −/− to TgSpi1FA +/+ . For better visualization, only one * was written for all P values ( P < 0.05), even if more highly significant.
Article Snippet: Single-cell suspensions of freshly collected bone marrow cells were immunostained with APC-H7 (560185, BD Biosciences) or APCeFluor780 (eBioscience 47-1172-82) -conjugated rat anti-KIT, FITC-conjugated rat anti-CD71 (553266, BD Biosciences), APC-conjugated rat anti-Ter119 (557909, BD Biosciences) and PE-conjugated streptavidin (554061, BD Biosciences) and biotin-conjugated rat anti-CD123 (555070, BD Biosciences) antibodies for the detection of erythroid progenitor (CFU-E) cells, as previously described [ ]; FITC-conjugated rat anti-CD11b (553310, BD Biosciences), PerCP-Cy TM 5.5-conjugated rat anti-mouse CD19 (45-0193-82, eBioscience) and PE-conjugated rat anti-mouse CD4 (553049, BD Biosciences), and APC-conjugated rat anti-myeloid CD8 (553035, BD Biosciences) and PE-Cy TM 7- conjugated rat anti-myeloid B220 (25-0452-82, eBioscience) antibodies were used for the detection of freshly collected bone marrow cells.
Techniques: Incubation, Flow Cytometry